ES8601301A1 - Un metodo para producir celulas cuyas respuestas inmunologicas humorales especificas de antigeno han sido moduladas. - Google Patents

Un metodo para producir celulas cuyas respuestas inmunologicas humorales especificas de antigeno han sido moduladas.

Info

Publication number
ES8601301A1
ES8601301A1 ES527138A ES527138A ES8601301A1 ES 8601301 A1 ES8601301 A1 ES 8601301A1 ES 527138 A ES527138 A ES 527138A ES 527138 A ES527138 A ES 527138A ES 8601301 A1 ES8601301 A1 ES 8601301A1
Authority
ES
Spain
Prior art keywords
medicament
manufacture
substituted guanine
aldose
cellular responses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES527138A
Other languages
English (en)
Spanish (es)
Other versions
ES527138A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/439,846 external-priority patent/US4539205A/en
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Publication of ES527138A0 publication Critical patent/ES527138A0/es
Publication of ES8601301A1 publication Critical patent/ES8601301A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES527138A 1982-11-09 1983-11-08 Un metodo para producir celulas cuyas respuestas inmunologicas humorales especificas de antigeno han sido moduladas. Expired ES8601301A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/439,846 US4539205A (en) 1982-11-09 1982-11-09 Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US06/546,679 US4643992A (en) 1982-11-09 1983-11-01 Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives

Publications (2)

Publication Number Publication Date
ES527138A0 ES527138A0 (es) 1985-11-01
ES8601301A1 true ES8601301A1 (es) 1985-11-01

Family

ID=27032191

Family Applications (1)

Application Number Title Priority Date Filing Date
ES527138A Expired ES8601301A1 (es) 1982-11-09 1983-11-08 Un metodo para producir celulas cuyas respuestas inmunologicas humorales especificas de antigeno han sido moduladas.

Country Status (15)

Country Link
US (1) US4643992A (Direct)
EP (1) EP0112632B1 (Direct)
AU (1) AU568325B2 (Direct)
CA (1) CA1236401A (Direct)
DE (1) DE3382156D1 (Direct)
DK (1) DK167898B1 (Direct)
ES (1) ES8601301A1 (Direct)
FI (1) FI87733C (Direct)
GR (1) GR78733B (Direct)
IE (1) IE56701B1 (Direct)
IL (1) IL70164A (Direct)
NO (1) NO174215C (Direct)
NZ (1) NZ206208A (Direct)
PT (1) PT77636B (Direct)
WO (1) WO1984001898A1 (Direct)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849411A (en) * 1982-11-09 1989-07-18 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5476659A (en) * 1982-11-09 1995-12-19 The Scripps Research Institute Cancerous B cell treatment using substituted nucleoside derivatives
US4900675A (en) * 1983-11-01 1990-02-13 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-β-aldoglycosidyl) derivatives
US5166141A (en) * 1983-11-01 1992-11-24 Scripps Clinic And Research Foundation Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
US5093318A (en) * 1983-11-01 1992-03-03 Scripps Clinic And Research Foundation Immunostimulating guanosine derivatives and their pharmaceutical compositions
FR2560212B1 (fr) * 1984-02-24 1989-12-29 Unicet Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
US5011828A (en) * 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods
ZA869297B (en) * 1985-12-13 1987-11-25 Scripps Clinic Res Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-beta-aldoglycosidyl)derivatives
US6060459A (en) * 1987-10-28 2000-05-09 Pro-Neuron, Inc. Enhancing blood cell count with oxypurine nucleosides
US4880784A (en) * 1987-12-21 1989-11-14 Brigham Young University Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives
US4902985A (en) * 1988-02-25 1990-02-20 Raytheon Company Microwave reflectiion amplifiers having increased bandwidth
GB2216416B (en) * 1988-03-11 1992-06-24 Sandoz Ltd Nucleobase source for the stimulation of the immune system
ZA893063B (en) * 1988-04-27 1990-01-31 Immunomedics Inc Improved radiotherapy
WO1994011003A1 (en) * 1992-11-13 1994-05-26 The Scripps Research Institute Cancerous b cell treatment using substituted nucleoside derivatives
US5786359A (en) * 1994-05-27 1998-07-28 The Scripps Research Institute N9 alkyl or aralkyl derivatives of 7, 8-disubstituted guanines
US5441942A (en) * 1994-05-27 1995-08-15 The Scripps Research Institute 2'3'-dideoxy-2',3'-didehydro-7,8-disubstituted guanosines and their immunostimulative effect
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US20030100520A1 (en) * 1997-01-21 2003-05-29 Philip Needleman Immunological process and constructs for increasing the hdl cholesterol concentration by dna vaccination
WO1999057120A1 (en) 1998-05-04 1999-11-11 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6562801B1 (en) * 1999-04-15 2003-05-13 Board Of Regents, The University Of Texas System PpGpp and pppGpp as immunomodulatory agents
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
EP1334104A2 (en) 2000-07-07 2003-08-13 Neotherapeutics, Inc. Methods for treatment of drug-induced peripheral neuropathy and related conditions
US20030138769A1 (en) * 2000-08-16 2003-07-24 Birkett Ashley J. Immunogenic HBc chimer particles having enhanced stability
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
EP1395262A4 (en) * 2001-06-15 2006-04-12 Ribapharm Corp NUCLEOSIDE-VACCINE-ADJUVANTS
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
US7361352B2 (en) * 2001-08-15 2008-04-22 Acambis, Inc. Influenza immunogen and vaccine
US20030175863A1 (en) * 2001-08-15 2003-09-18 Birkett Ashley J. Influenza immunogen and vaccine
US7321033B2 (en) * 2001-11-27 2008-01-22 Anadys Pharmaceuticals, Inc. 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
US7351413B2 (en) * 2002-02-21 2008-04-01 Lorantis, Limited Stabilized HBc chimer particles as immunogens for chronic hepatitis
CA2537450C (en) 2003-09-05 2012-04-17 Anadys Pharmaceuticals, Inc. Administration of tlr7 ligands and prodrugs thereof for treatment of infection by hepatitis c virus
PT2561872E (pt) 2004-12-17 2014-12-18 Anadys Pharmaceuticals Inc Compostos 3h-oxazolo[4,5-d]pirimidin-2-ona 3,5-di- -substituídos e 3,5,7-tri-substituídos e seus pró-fármacos
US7781581B2 (en) 2005-11-21 2010-08-24 Anadys Pharmaceuticals, Inc. Process for the preparation of 5-amino-3H-thiazolo[4,5-d]pyrimidin-2-one
BRPI0713680A2 (pt) * 2006-06-22 2012-10-23 Anadys Pharmaceuticals Inc composto, composição farmacêutica e métodos de modulação das atividades imuno da citocina, de tratamento de infecção de vìrus da hepatite c em paciente e de tratamento de desordem de proliferação relacionada em mamìfero carecido do mesmo
BRPI0714831A2 (pt) 2006-07-18 2013-04-02 Anadys Pharmaceuticals Inc composto, composiÇço farmacÊutica e mÉtodos de modulaÇço de atividades imuno da citoquina em paciente, de tratamento de infecÇço de vÍrus c da hepatite em paciente e de desordem relacionada com proliferaÇço em mamÍfero necessitado do mesmo
CA2695399C (en) 2007-08-02 2017-10-17 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope influenza vaccines
AU2008331800A1 (en) 2007-12-03 2009-06-11 President And Fellows Of Harvard College Chlamydia antigens
JP2012510289A (ja) 2008-12-03 2012-05-10 プロティア ワクチン テクノロジーズ リミテッド グルタミルｔＲＮＡ合成酵素（ＧｔＳ）フラグメント
TW201639852A (zh) 2008-12-09 2016-11-16 吉李德科學股份有限公司 用於製備可用作類鐸受體調節劑之化合物的中間體化合物
WO2011067758A2 (en) 2009-12-02 2011-06-09 Protea Vaccine Technologies Ltd. Immunogenic fragments and multimers from streptococcus pneumoniae proteins
AU2011360572B2 (en) 2011-02-22 2017-03-02 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
WO2013150518A1 (en) 2012-04-01 2013-10-10 Rappaport Family Institute For Research In The Medical Sciences Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies
CA2944768C (en) 2014-04-03 2022-08-30 Biondvax Pharmaceuticals Ltd. Compositions of multimeric-multiepitope influenza polypeptides and their production
NZ728072A (en) 2014-07-11 2018-06-29 Gilead Sciences Inc Modulators of toll-like receptors for the treatment of hiv
CA2960436C (en) 2014-09-16 2021-01-05 Gilead Sciences, Inc. Solid forms of a toll-like receptor modulator

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1174077A (en) * 1967-02-18 1969-12-10 Ajinomoto Kk Process for Preparing 8-Mercaptopurine Derivatives

Also Published As

Publication number Publication date
DK334884D0 (da) 1984-07-06
WO1984001898A1 (en) 1984-05-24
IE832605L (en) 1984-05-09
IL70164A0 (en) 1984-02-29
DK334884A (da) 1984-07-06
US4643992A (en) 1987-02-17
NZ206208A (en) 1987-03-31
EP0112632B1 (en) 1991-02-06
FI842748A0 (fi) 1984-07-09
DK167898B1 (da) 1994-01-03
FI87733B (fi) 1992-11-13
IE56701B1 (en) 1991-11-06
EP0112632A3 (en) 1985-01-23
FI87733C (fi) 1993-02-25
IL70164A (en) 1988-06-30
DE3382156D1 (de) 1991-03-14
PT77636B (en) 1986-03-19
EP0112632A2 (en) 1984-07-04
NO174215B (no) 1993-12-20
AU568325B2 (en) 1987-12-24
GR78733B (Direct) 1984-10-02
NO842765L (no) 1984-07-06
CA1236401A (en) 1988-05-10
ES527138A0 (es) 1985-11-01
FI842748L (fi) 1984-07-09
PT77636A (en) 1983-12-01
AU2330284A (en) 1984-06-04
NO174215C (no) 1994-03-30

Similar Documents

Publication Publication Date Title
ES8601301A1 (es) Un metodo para producir celulas cuyas respuestas inmunologicas humorales especificas de antigeno han sido moduladas.
IE830227L (en) Pyrazolooxazines
DE3362784D1 (en) Process for preparing free-flowing ethylcellulose microcapsules
DE3267039D1 (en) Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle
JPS5745197A (en) O-alpha-glycoside and manufacture
AU5317279A (en) Hydroxypropyl-triazole derivatives and their use as antimycotic agents
ES8200094A1 (es) Procedimiento para la obtencion de alquilureas
IL64472A0 (en) Pharmaceutical compositions containing tricyclic cytosin derivatives,certain new compounds of this class and their production
ES8506704A1 (es) Un procedimiento para preparar derivados de aminoglicosido
PT70948A (en) Peptides having ubiquitin-like-activity
MY102071A (en) Pyrroloindole derivatives.
GR78106B (Direct)
GR81385B (Direct)
ES8406468A1 (es) Procedimiento para la obtencion de derivados de terc.-butanol sustituidos
ES8103112A1 (es) Procedimiento para la obtencion de pseudo-trisacaridos
GB2009180A (en) 25-Alkyl Cholesterol Derivatives
JPS54142194A (en) Manufacture of active carbon
ATE16139T1 (de) Elektrolyt fuer bleiakkumulator und diesen elektrolyt enthaltender akkumulator.
IL80928A (en) Method of modulation of animal cellular responses with compositions containing 8-(1'-beta-aldoglycosidyl-isoxanthopterin derivatives
SU630302A1 (ru) Способ преработки отходов медьсодержащих сплавов
ES484785A1 (es) Procedimiento para la obtencion de esteramidas de acido n- iso-propil-s.(1,6-dihidro-6(tio)oxo-pirimidazin(1)il-metil)-tiolfosforico, de accion plaguicida
ES2004522A6 (es) Nuevo procedimiento para la preparacion de 4-(6' - metoxi-2'-naftil)butan-2-ona.
JPS53124544A (en) Adhesive composition having improved temperature stability
DE2961506D1 (en) N-cyclohexyl-n-methoxy-acetoacetamide, process for its preparation and its use to prepare o-methyl-n-cyclohexyl-2,5-dimethyl-furane-3-hydroxamic acid
ES479478A1 (es) Procedimiento para preparar derivados del isocromano.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050712